-Innovation is the product of teamwork.
-Engineers and scientists play a critical role.
-Scientific research is insufficiently rewarded financially.
-Taxes can boost innovation by funding human capital investment and basic research.
-The amount of investment is important -who owns financial assets is not.
In formulating taxation and public investment policies, we should carefully consider data and the peer reviewed literature. Claims that we can drive more innovation and growth through a higher concentration of resources in the hands of a small number of billionaires -while providing fewer resources to middle and upper middle-class knowledge workers -are not empirically supported.
Opponents of ultra--high net worth taxes argue that taxing billionaires will drive down "innova8on" (see here, here and here). And indeed, if providing revenue to the government were the equivalent of destroying capital, it probably would. However, taxing billionaires more 1 -and using the revenue to tax other people less or subsidize public investments that more directly contribute to innova8on-could boost the rate of innova8on.
Presumably, "innova8on" in this context means scien8fic or technological advances that lead to improvements in produc8vity, or improvements in quality of life or health. Or new business processes that lead to similarly posi8ve outcomes.
Innova8on is oJen the work of a large group of people working together. Large companies and even startups do not consist exclusively of a founder or figurehead, but rather of a team of highly educated skilled workers building on scien8fic and technical discoveries and legal and financial infrastructure which predate them.
It is therefore difficult to aNribute innova8on to a single person or class of persons. However, there are two readily available proxies for who drives innova8on: Nobel prizes in scien8fic fields and patent authorship. The overlap between Nobel prize winners in science and known billionaires is zero. The cash por8on of the Nobel prize is approximately $1.1 million. The medal can be auc8oned off for perhaps another $2 million. Prize winners can write books, lecture, or teach, but these are not par8cularly lucra8ve ac8vi8es, even for most Nobel prize winners. Most Nobel prize winners are late--career academic scien8sts who earned modest compensa8on for most of their working lives. Scien8sts working in industry are typically paid beNer, but rarely above a six--figure salary.
A recent analysis that found links between statutory state income and state corporate tax rates and the loca8on 1 of innova8on controlled for R&D tax credits, GDP per capita, popula8on density, and state fixed effects. However, the ability to fund R&D tax credits and fund public investments (educa8on; infrastructure) that support high produc8vity and high popula8on density depends on tax revenue or previous borrowing that requires higher tax revenue. Thus, the study over--controlled and effec8vely assumed that taxes were a pure drag on the economy rather than a source of funding for public investment.
The Nobel Peace Prize, which is given to powerful poli8cal leaders, presumably should not count as "innova8on" 2 although reducing the risk of war is an important contribu8on to social welfare).
Patents are an imperfect proxy for innova8on. Many patents are not valuable, and many innova8ons are not 3 patentable. But there are few beNer proxies available.
Electronic copy available at: https://ssrn.com/abstract=3335386
Nobel prize winners can help an early--stage biotech raise seed capital, but this doesn't seem to otherwise improve chances of success (which are always slim).
A modest salary for decades, plus a few million dollars toward the end of one's life is not enough wealth or income for someone to be subjected to ultra--high net--worth taxes. To the extent that ultra--high net--worth taxes disincen8vize work, they will not discourage future Nobel prize winners.
Nobel prizes are awarded for important but abstract research with many poten8al applica8ons. Typically, such basic research creates tremendous value for society, but the value that is created cannot be captured and mone8zed by the innova8ve scien8sts who create it.
The patent system is meant to reward innova8on by gran8ng a 8me--limited legal monopoly for useful methods or processes and thereby facilitate value capture. Patents are typically authored by scien8sts, engineers, and doctors. Occasionally they may be authored by corporate managers, consultants, and entrepreneurs. Patent authors are overwhelmingly middle class and upper middle class, not billionaires. Patents per capita are strongly linked to the share of the popula8on with advanced degrees in science and engineering. There is a close connec8on between scien8sts, engineers, and innova8on.
Commercializing and scaling innova8ve technologies depends on many non--technical business skills, such as the ability to ar8culate a vision, to know what customers want, to tell the company's story to investors and customers, and to aNract and retain talent.
Steve Jobs and Elizabeth Holmes both excelled at these skills. But salesmanship and charisma or even persistence are not enough. The important difference between Apple and Theranos is that the engineers at Apple were able to solve the scien8fic and technical problems that were required to make their products work, while those at Theranos could not. (If Holmes or her investors had scien8fic training-or listened to advice from those who did-they might have realized how unlikely their venture was to succeed before burning $100 million of capital).
Few of the scien8sts or engineers whose work leads to innova8ve companies' success will become billionaires as a result. The inventor of Valium-one of the most successful drugs in history-was paid a single dollar for this innova8on by his employer, Roche. Early stage companies don't seem to care enough about taxes to invest much in tax planning, even though it would poten8ally boost the value of their companies (see here and here).
The ability to raise capital is important to a companies' success, and billionaires clearly do have a lot of capital to invest. But the amount of capital available for investment in each asset class may be far more important to innova8on than who owns the capital or who decides how it will be invested. (see also here). 4 U.S. corporate law has separated ownership of firms from control of firms. The iden8ty of investors in large firms is more or less irrelevant to the opera8on of businesses and the extent to which they innovate. ShiJing tax burdens so that a few less shares are held by billionaires and a few more are held by people who are middle class is unlikely to affect opera8ons much. Very few money managers can beat the stock market. Even venture capitalists typically just buy a porholio with a lot of risk but do not consistently generate alpha (high risk--adjusted returns).
Public policy can be used to promote innova8on by raising taxes and extensively funding high quality science, math, and engineering educa8on, or by encouraging immigra8on of people with those skills.
Billionaires can promote innova8on by dona8ng money to universi8es or hospitals or ar8sts. But so too can governments through taxa8on and public investment, for example through the NSF, NIH, NEA, DARPA, Medicare or general funding for Universi8es, healthcare or the arts. Public grant--making ins8tu8ons typically have expert review mechanisms that are intended to allocate funding based on scien8fic merit, not poli8cal ideology.
Ultra--high net worth individuals typically direct a rela8vely high por8on of their philanthropy to universi8es, hospitals and cultural ins8tu8ons. But philanthropy for all givers-not just billionaires-adds up to only around 2% of GDP. The very wealthy give at higher rates than most, and to the extent that taxing wealth could reduce such produc8ve charitable dona8ons, it may be advisable to use some of the revenue to increase public funding. A majority of scien8sts overwhelmingly agree that governments should play an important role in the economy.
The most important connec8on between taxa8on and innova8on may be the extent to which taxes fund public investments and research that contribute to innova8on. Domes8c centers of innova8on (measured by patents per capita) are almost all located in the northeast corridor, the west coast, Illinois, and Michigan-high tax areas with high levels of public investment and strong universi8es. Interna8onally, centers of innova8on are located primarily in East Asia and con8nental Europe.
These are not hotbeds of cut--throat individualism and an8--government sen8ment.
The best argument that can be made for a link between inequality and innova8on might be that those with high 4 incomes and high wealth are more risk--tolerant and therefore more inclined to invest in high risk asset classes like venture capital. But if wealth were distributed more evenly, financial intermediaries with long 8me horizons such as pensions, insurance companies, banks, industrial corpora8ons could invest in Venture Capital firms or Entrepreneurial ventures on behalf of smaller investors who are more risk averse in their individual capaci8es. Intermediaries can also reduce informa8on and search costs Indeed, ins8tu8onal investors already account for the vast majority of VC investment.
Some members of the Forbes 400 founded companies with a strong reputa8on for innova8on.
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As noted above, those companies' success was built on the work of thousands of other people.
In addi8on, the Forbes 400 is not a representa8ve sample of billionaires. Instead, it is a self--selected subset: those who wish to publicize their wealth.
Many ultra--high net--worth individuals-par8cularly those who inherited their wealth-place a premium on privacy. Through the use of investment vehicles and trusts whose beneficial ownership need not be publicly disclosed and personal discre8on, it is easy for them to maintain their privacy.
Entrepreneurs who are directly involved in the management of companies and need to aNract investors and talent may find it advantageous to publicize their financial success.
But for those who inherited their wealth and do not ac8vely manage a business themselves, there are few advantages to fame and the scru8ny it brings, and many disadvantages. The disadvantages range from the banal-aNrac8ng unwanted solicita8ons for investment or charitable contribu8ons-to the serious-becoming a target for fraud or pukng one's family at risk for kidnapping.
Even with strong selec8on bias toward entrepreneurship in the Forbes 400 list, a substan8al propor8on inherited much of their wealth. Heirs collec8ng dividends and interest are not obviously more innova8ve than re8rees collec8ng Social Security or Medicare benefits.
One of the most important prerequisites to innova8on may be hard work. Evidence from experiments and quasi random exogenous shocks shows that increasing wages increases work effort and hours. However, increasing wealth reduces work hours (see also here). Thus, taxing wealth more and wages less would lead to higher levels of effort and higher levels of produc8vity.
In formula8ng taxa8on and public investment policies, we should carefully consider data and the peer reviewed literature. Claims that we can drive more innova8on and growth through a higher concentra8on of resources in the hands of a small number of billionaires-while providing fewer resources to middle and upper middle--class knowledge workers-are not empirically supported.
Michael Simkovic is a Professor of Law and Accoun&ng at the University of Southern California.
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These companies are not always quite as innova8ve as is oJen assumed. 
